CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 4 Open-market sale Chief Medical Officer sold 29,000 shares at an average $37.18 ($1,078,261)
- 4 Open-market sale Chief Medical Officer sold 60,000 shares at an average $34.82 ($2,089,472)
- 4 Open-market sale General Counsel and Secretary sold 16,926 shares at an average $29.15 ($493,398)
- 4 Open-market sale General Counsel and Secretary sold 1,597 shares at an average $28.37 ($45,311)
- 4 Open-market sale General Counsel and Secretary sold 16,256 shares at an average $28.12 ($457,077)
- 4 Open-market sale General Counsel and Secretary sold 8,125 shares at $22.05 ($179,156)
- 4 Open-market buy Director bought 425,531 shares at $23.50 ($9,999,979)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at $12.20 ($366,000)
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at $13.04 ($391,200)
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $18.92 ($567,636)
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $17.65 ($529,491)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $19.09 ($572,818)
Page 5 of 14 · 264 filings